Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
Hangzhou Diagens Biotechnology Co (HKSE:02526) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Hangzhou Diagens Biotechnology Co's EV-to-EBIT for today is
Hangzhou Diagens Biotechnology Co's current Enterprise Value is HK$31,940.11 Mil.
Hangzhou Diagens Biotechnology Co's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was HK$-71.96 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Hangzhou Diagens Biotechnology Co's EV-to-EBITDA for today is:
Hangzhou Diagens Biotechnology Co's current Enterprise Value is HK$31,940.11 Mil.
Hangzhou Diagens Biotechnology Co's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was HK$-69.43 Mil.
Hangzhou Diagens Biotechnology Co's current Enterprise Value is HK$31,940.11 Mil.
Hangzhou Diagens Biotechnology Co's Revenue for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was HK$82.18 Mil.
Hangzhou Diagens Biotechnology Co's current Enterprise Value is HK$31,940.11 Mil.
Hangzhou Diagens Biotechnology Co's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was HK$-38.37 Mil.
Hangzhou Diagens Biotechnology Co's current Enterprise Value is HK$31,940.11 Mil.
Hangzhou Diagens Biotechnology Co's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was HK$-38.58 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hangzhou Diagens Biotechnology Co Enterprise Value Related Terms
Hangzhou Diagens Biotechnology Co Enterprise Value Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hangzhou Diagens Biotechnology Co Enterprise Value Chart
Hangzhou Diagens Biotechnology Co Annual Data
Trend
Dec23
Dec24
Dec25
Enterprise Value
0.00
0.00
0.00
Hangzhou Diagens Biotechnology Co Quarterly Data
Dec23
Dec24
Sep25
Dec25
Jun26
Enterprise Value
0.00
0.00
0.00
0.00
26,841.95
HKSE:02526 vs ABT, SYK, MDT: Enterprise Value Comparison
For the Medical Devices subindustry, Hangzhou Diagens Biotechnology Co's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hangzhou Diagens Biotechnology Co Enterprise Value vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Hangzhou Diagens Biotechnology Co's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Hangzhou Diagens Biotechnology Co's Enterprise Value falls into.
Hangzhou Diagens Biotechnology Co Enterprise Value Calculation
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Enterprise Value of HK$31,940.11 Mil mean?
Hangzhou Diagens Biotechnology Co (HKSE:02526) has a Enterprise Value of HK$31,940.11 Mil as of Aug. 14, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Hangzhou Diagens Biotechnology Co and its competitors.
Is Hangzhou Diagens Biotechnology Co's Enterprise Value too high?
Hangzhou Diagens Biotechnology Co's current Enterprise Value is HK$31,940.11 Mil. Overall, Hangzhou Diagens Biotechnology Co has a GF Score™ of 8/100, reflecting its overall financial health beyond just this single metric.
How does Hangzhou Diagens Biotechnology Co's Enterprise Value compare to ABT and SYK?
Hangzhou Diagens Biotechnology Co's Enterprise Value of HK$31,940.11 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Medical Devices & Instruments company?
A good Enterprise Value depends on the Medical Devices & Instruments industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Hangzhou Diagens Biotechnology Co and its competitors. Hangzhou Diagens Biotechnology Co's current Enterprise Value is HK$31,940.11 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hangzhou Diagens Biotechnology Co stock overvalued right now?
Hangzhou Diagens Biotechnology Co (HKSE:02526) has a current Enterprise Value of HK$31,940.11 Mil. The current Enterprise Value is HK$31,940.11 Mil. Hangzhou Diagens Biotechnology Co's overall GF Score™ is 8/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Hangzhou Diagens Biotechnology Co (HKSE:02526), the current Enterprise Value is HK$31,940.11 Mil as of Aug. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Hangzhou Diagens Biotechnology Co Ltd and its subsidiaries are involved in the development and commercialisation of medical imaging artificial intelligence technologies and medical imaging equipment. It has self-developed a diversified portfolio, including six medical imaging software products, three commercialized medical devices, four key reagents and consumables and two technology licensing offerings. Its Core Product, AI AutoVision, is an auxiliary diagnostic software designed to undertake intelligent analysis on chromosome karyotyping. The majority of the company's revenue is derived from Technology Licensing, mainly in the Chinese mainland.
8GF Score
Get the complete analysis for HKSE:02526
Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02526 has been successfully added to your 
